NCT07282600 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes Status RECRUITING Phase PHASE3
NCT07282574 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) Status RECRUITING Phase PHASE2
NCT07282353 A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA Status RECRUITING Phase PHASE3
NCT07282210 Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype Status NOT_YET_RECRUITING Phase PHASE2
NCT07281937 A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07281495 Taldefgrobep Alfa in Adults With Overweight and Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT07281105 EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study Status COMPLETED Phase PHASE2
NCT07281079 A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome Status RECRUITING Phase PHASE3
NCT07281014 Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing Status RECRUITING Phase PHASE4
NCT07280702 Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT07280299 Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease Status NOT_YET_RECRUITING Phase PHASE2
NCT07279493 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke Status RECRUITING Phase PHASE2
NCT07279194 Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes Status RECRUITING Phase PHASE3
NCT07278492 NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome Status NOT_YET_RECRUITING Phase PHASE1
NCT07277881 The Effect of Reversal of Remimazolam Sedation With Flumazenil on Cognitive Function in Patients Undergoing Hip Arthroplasty Under Spinal Anesthesia Status NOT_YET_RECRUITING Phase PHASE4
NCT07277660 A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis Status RECRUITING Phase PHASE2
NCT07277452 Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer Status NOT_YET_RECRUITING Phase PHASE2